Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NBS [AMEX]
Neostem, Inc.
Index- P/E- EPS (ttm)-0.37 Insider Own4.08% Shs Outstand193.80M Perf Week0.00%
Market Cap114.34M Forward P/E- EPS next Y-0.16 Insider Trans12.84% Shs Float190.91M Perf Month-7.81%
Income-43.93M PEG- EPS next Q-0.04 Inst Own11.97% Short Float2.49% Perf Quarter-3.28%
Sales29.44M P/S3.88 EPS this Y-18.25% Inst Trans-1.28% Short Ratio4.28 Perf Half Y-10.61%
Book/sh0.17 P/B3.47 EPS next Y5.90% ROA-35.54% Target Price3.25 Perf Year63.89%
Cash/sh0.03 P/C21.21 EPS next 5Y- ROE-72.16% 52W Range0.37 - 0.84 Perf YTD-1.67%
Dividend- P/FCF- EPS past 5Y0.00% ROI-57.78% 52W High-29.76% Beta0.74
Dividend %- Quick Ratio0.94 Sales past 5Y337.49% Gross Margin19.29% 52W Low59.46% ATR0.03
Employees97 Current Ratio0.95 Sales Q/Q103.67% Oper. Margin-175.24% RSI (14)49.26 Volatility4.46% 5.40%
OptionableNo Debt/Eq0.13 EPS Q/Q9.12% Profit Margin-179.29% Rel Volume0.56 Prev Close0.57
ShortableYes LT Debt/Eq0.06 EarningsNov 13 Payout- Avg Volume1.11M Price0.59
Recom1.60 SMA203.78% SMA50-4.62% SMA200-8.29% Volume619,919 Change3.51%
09-Jul-12Upgrade WBB Securities Buy → Strong Buy $2
19-Jan-12Upgrade WBB Securities Speculative Buy → Buy $1.85 → $2
16-Sep-11Initiated JMP Securities Mkt Outperform $3
16-Aug-11Upgrade WBB Securities Hold → Speculative Buy
03-Dec-10Initiated Morgan Joseph Buy $3.50
29-Jun-10Upgrade WBB Securities Sell → Hold $1.85
03-Jun-10Initiated WBB Securities Sell $2
27-May-10Initiated Maxim Group Buy $5
12-Mar-10Initiated Roth Capital Buy $2.50
20-May-13 11:38AM  A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 at Seeking Alpha
17-May-13 01:04PM  NEOSTEM, INC. Financials EDGAR Online Financials
16-May-13 06:13PM  4 Healthcare Stock Stories For Thursday Investing Wellness at Wall St. Cheat Sheet
07:38AM  NeoStem announces geographic expansion of IP coverage of AMR-001 theflyonthewall.com
07:32AM  InPlay: Neostem announces geographic expansion of intellectual property coverage of cardiovascular asset AMR-001 Briefing.com
07:30AM  NeoStem Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001 GlobeNewswire
14-May-13 08:16AM  3 Biotech Stocks With Potential at Seeking Alpha
07:30AM  NeoStem to Present at Multiple Conferences in May GlobeNewswire
13-May-13 07:30AM  NeoStem's Subsidiary, Progenitor Cell Therapy, to Provide Autologous and Allogeneic Cellular Therapy Services to MedStar Georgetown University Hospital GlobeNewswire
11-May-13 10:52PM  5 Stocks To Watch For Gains Next Week at Seeking Alpha
10-May-13 01:06AM  InPlay: Neostem clarifies earlier release; co NOT issuing new securities Briefing.com +5.66%
09-May-13 07:54PM  NeoStem Clarification: No New Securities Being Issued GlobeNewswire
04:33PM  NeoStem files to sell $7.99M of common stock theflyonthewall.com
04:06PM  NeoStem CEO's Letter to Shareholders GlobeNewswire
09:05AM  NEOSTEM, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-May-13 03:21AM  Interviewing Dr. Losordo: The Promising Development Of CD34 Cells at Seeking Alpha
03-May-13 08:50AM  NeoStem Announces Closing of Public Offering of Common Stock GlobeNewswire +5.56%
01-May-13 05:33AM  Stem Cells: Invest At Your Own Peril at Seeking Alpha
01:12AM  NEOSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
30-Apr-13 06:28PM  NeoStem Announces Partial Exercise of Underwriters' Over-Allotment Option GlobeNewswire -20.63%
09:41AM  NEOSTEM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
29-Apr-13 08:57PM  NeoStem Announces Pricing of Public Offering of Common Stock GlobeNewswire
04:22PM  NeoStem intends to offer common stock, no amount given at theflyonthewall.com
04:16PM  InPlay: Neostem announces proposed public offering of common stock; terms not disclosed Briefing.com
04:15PM  NeoStem Announces Proposed Public Offering of Common Stock GlobeNewswire
09:17AM  NEOSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements a EDGAR Online
08:49AM  NeoStem's Subsidiary, Progenitor Cell Therapy, Enters Into a Services Agreement With Sentien Biotechnologies, Inc. GlobeNewswire
28-Apr-13 01:34AM  Regenerative Medicine's Time Has Come at Seeking Alpha
25-Apr-13 03:03PM  Stem Cells: Dreamers, Fools, And The Valley Of Death at Seeking Alpha
11:50AM  NeoStem: A Simple Look At Regenerative Medicine at Seeking Alpha
24-Apr-13 07:56AM  Abu Dhabi Shares Jump Most Since 2009 as NBAD Spurs Bank Rally at Bloomberg
23-Apr-13 11:15AM  RedChip Emerging Growth Showcase Takes Place May 1 GlobeNewswire
22-Apr-13 05:30AM  An Industry Outlook With Analyst Vernon Bernardino at Seeking Alpha
19-Apr-13 03:03PM  RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report" GlobeNewswire
15-Apr-13 04:12AM  5 Biotechnology Stocks That Greatly Outperformed The Market In Q1 at Seeking Alpha
12-Apr-13 01:40PM  RedChip TV Announces Guest Lineup for This Week's "RedChip Money Report" GlobeNewswire
11-Apr-13 08:36AM  The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference GlobeNewswire
10-Apr-13 04:00AM  The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy at Seeking Alpha +6.25%
09-Apr-13 02:09PM  Gain An Innovation, Strategic Edge With Partnerships at Investor's Business Daily
12:01AM  Stock Price-Band Pilots, Nibor, Starr Suit: Compliance at Bloomberg
07-Apr-13 03:32AM  5 Stocks To Watch Next Week For Gains at Seeking Alpha
04-Apr-13 12:47AM  Asian Dollar Bond Sales Pause for Longest Stretch Since February at Bloomberg +6.06%
02-Apr-13 12:35AM  Sharjah Islamic Plans Dollar Sukuk as Issues Surge to July High at Bloomberg
01-Apr-13 02:58PM  Will AMR-001 Lead Neostem To The Promised Land? at Seeking Alpha
07:30AM  NeoStem to Present at Multiple Conferences in April GlobeNewswire
28-Mar-13 08:10AM  InPlay: Neostem awarded second year of NIAID research grant for the development of VSEL technology for radiation exposure Briefing.com
08:09AM  NeoStem Awarded Second Year of NIAID Research Grant for the Development of VSEL Technology for Radiation Exposure GlobeNewswire
27-Mar-13 11:51AM  Biotechnology Super Panel Talks Development, Marketing And The Future at Seeking Alpha
26-Mar-13 09:01AM  Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors at Seeking Alpha
22-Mar-13 08:57AM  The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference GlobeNewswire
20-Mar-13 06:38AM  InPlay: Neostem CEO sends letter to shareholders with updates Briefing.com
12:30AM  NEOSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
19-Mar-13 06:30PM  NeoStem CEO's Letter to Shareholders GlobeNewswire
09:15AM  Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself at Seeking Alpha
18-Mar-13 07:30AM  NeoStem's Subsidiary, Progenitor Cell Therapy, Launches Web-Based Service for Real-Time Cell Therapy Product Tracking GlobeNewswire
17-Mar-13 03:54AM  3 Biotech Stocks That Are Set-Up Nicely For Growth at Seeking Alpha
14-Mar-13 01:04PM  NEOSTEM, INC. Financials EDGAR Online Financials
13-Mar-13 05:45PM  4 Healthcare Stock Stories Not To Be Overlooked at Wall St. Cheat Sheet
08:32AM  InPlay: Neostem announces intellectual property expansion in cardiovascular disease Briefing.com
07:30AM  NeoStem Announces Intellectual Property Expansion in Cardiovascular Disease GlobeNewswire
12-Mar-13 08:32PM  New Star Analyst Rankings for Neostem, Inc. Common Stock StarMine
11-Mar-13 08:57AM  3 Undiscovered Biotech Companies For The Healthcare Investor at Seeking Alpha
07:52AM  NEOSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online
07:30AM  NeoStem Announces 2012 Year End Financial Results and Business Update GlobeNewswire
06:09AM  NEOSTEM, INC. Files SEC form 10-K, Annual Report EDGAR Online
10-Mar-13 06:08AM  The Weekend Blitz: A Discussion Of Investment Strategies And Investment Ideas at Seeking Alpha
08-Mar-13 03:15PM  4 Healthcare Stock Stories for Weekend Investor Wellness at Wall St. Cheat Sheet
07-Mar-13 07:30AM  InPlay: Neostem reports second data safety monitoring Board review: continue with PreSERVE AMI Phase 2 Trial as planned Briefing.com +11.32%
07:30AM  NeoStem Reports Second Data Safety Monitoring Board Review: Continue With PreSERVE AMI Phase 2 Trial as Planned GlobeNewswire
01-Mar-13 11:10AM  CEO of Perritt Capital Management to Appear on This Week's "RedChip Money Report" GlobeNewswire
08:20AM  U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwire
28-Feb-13 02:15PM  2012 Stem Cell Standouts And The Outlook For 2013 at Seeking Alpha
15-Feb-13 12:58PM  Manager of Royce Funds to Appear on This Week's "The RedChip Money Report" GlobeNewswire
13-Feb-13 03:36PM  2 Regenerative Medicine Plays For 2013 at Seeking Alpha
12-Feb-13 11:22AM  A Look At ImmunoCellular Therapeutics Just Prior To Interim Data at Seeking Alpha
11-Feb-13 07:51AM  NEOSTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
07:30AM  NeoStem Appoints Stephen W. Potter to Board of Directors GlobeNewswire
07-Feb-13 07:30AM  NeoStem to Present at Multiple Conferences in February GlobeNewswire
04-Feb-13 07:30AM  NeoStem's Vice President of Clinical Development and Regulatory Affairs to Present at Two Venues This Week GlobeNewswire
01-Feb-13 10:37AM  RedChip Issues Research Update on NeoStem, Inc. GlobeNewswire
29-Jan-13 11:54AM  "The RedChip Money Report" Begins Airing Nationally on Fox Business News GlobeNewswire
08:40AM  Stem Cell Therapy Companies: Underappreciated Outperformers at Seeking Alpha
28-Jan-13 11:19AM  Profit Growth On The Horizon For Investors Of 3 Companies Advancing Regenerative Medicine at Seeking Alpha
08:48AM  RedChip TV Announces Guest Lineup for This Week's "Money Report" GlobeNewswire
25-Jan-13 02:11PM  Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured at Seeking Alpha
23-Jan-13 08:20AM  Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements Marketwire
22-Jan-13 09:33AM  3 Regenerative Medicine Companies That Could Deliver In 2013 at Seeking Alpha
07:33AM  InPlay: Neostem announces grant of patent protecting further expansion of its CD34+ chemotactic stem cell product composition claim Briefing.com
07:30AM  NeoStem Announces Further Expansion of Intellectual Property Coverage GlobeNewswire
17-Jan-13 02:28PM  'Top Of The Class' Small Pharma Investments For 2013 Part II at Seeking Alpha
16-Jan-13 06:07PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
05:37PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
04:44PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
04:29PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
03:55PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
03:18PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
02:43PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
02:01PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
01:20PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
12:48PM  8:04 am Neostem subsidiary, Progenitor Cell Therapy, enters into a cell therapy manufacturing services agreement with Adaptimmune Briefing.com
NeoStem, Inc. engages in the development of proprietary cell therapy products. It is involved in the manufacture of cell therapy-based products, product and process development, cell and tissue processing, regulatory support, storage, distribution and delivery, and consulting services. The company also provides contract development and manufacturing services to clients advancing regenerative medicine product candidates in the regenerative medicine industry; adult stem cell collection and storage services; and therapy development utilizing T-cells for autoimmune and inflammatory conditions, including graft vs. host disease, type 1 diabetes, steroid resistant asthma, lupus, multiple sclerosis, and solid organ transplant rejection. In addition, it engages in developing AMR-001, a chemotactic hematopoietic stem cell product comprised of autologous bone marrow derived CD34+/CXCR4+ cells, which is in Phase II study for the treatment of damaged heart muscle; and researching and developing new therapies based on Very Small Embryonic-Like technology. It has a collaboration agreement with Becton-Dickinson. NeoStem, Inc. was founded in 1980 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERMAN RICHARD JDirectorDec 28Sale0.59146,57787,021146,923Jan 18 09:00 PM
BERMAN RICHARD JDirectorDec 27Sale0.612,7291,665293,500Jan 18 09:00 PM
Smith Robin LChairman of the Board and CEOSep 18Buy0.6936,00024,8401,749,533Sep 18 09:03 PM
BERMAN RICHARD JDirectorSep 18Sale0.6936,00024,840149,306Sep 18 09:02 PM
RimAsia Capital Partners Manag10% OwnerSep 17Sale0.7130,00021,156105,306Sep 18 09:02 PM